Share this article and save a life!
18.3 billion patient encounters at your fingertips. Game changer?
Advocate Health just plugged into Epic’s Cosmos platform, and the numbers are staggering.
300 million patient records. Real-world data. Instant access.
Here’s what this means for healthcare innovation:
Their DIVE team can now visualize patterns across populations that were invisible before. Think about it: rare disease clusters, medication effectiveness across demographics, social determinants impacting outcomes.
The platform has already powered 165 publications across 112 journals. From chronic disease surveillance to antibiotic resistance patterns.
But here’s what excites me most:
The “Look-Alikes” feature connects providers treating rare conditions. Imagine being the only doctor in your state treating a rare genetic disorder, then instantly connecting with 20 others who’ve seen similar cases.
No more practicing in isolation.
This isn’t just about big data. It’s about turning every patient encounter into collective learning.
When 60 million patients became part of Cosmos two years ago, skeptics worried about privacy and data security. Now we’re at 300 million, with health systems racing to join.
The April 28 Cosmos Symposium in Verona will showcase what’s next. But the real question is:
Can smaller health systems and FQHCs access these insights too? Or will data-driven care become another divide between the haves and have-nots?
Data democratization or data monopoly? The next 12 months will tell.
♻️ Repost if health data collaboration needs to include all providers, not just the giants.
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
